Nobel laureates Jennifer Doudna, David MacMillan, Paul Nurse and Venki Ramakrishnan joined the Isomorphic Labs Scientific Advisory Board.

The claim: all four named Nobel laureates (Jennifer Doudna, David MacMillan, Paul Nurse, Venki Ramakrishnan) joined Isomorphic Labs' Scientific Advisory Board around January 2023. TRUE: an Isomorphic Labs announcement, its website's advisory board listing or credible press coverage confirms that all four joined the board at or around that date. MOSTLY TRUE: all four joined, with a minor discrepancy in a detail the claim does not depend on, such as the exact date or the board's exact name. MIXED: two or three of the four are confirmed as members. MOSTLY FALSE: only one is confirmed, or they joined a different advisory role or body at Isomorphic. FALSE: none of them joined, or Isomorphic had no such board.

Set before the research began.

1. E1 Isomorphic Labs announces new Scientific Advisory Board - Isomorphic Labs Isomorphic Labs · 9 January 2023 Own record

   “LONDON, Jan. 9, 2023 - Isomorphic Labs, a digital biology company redefining drug discovery from first principles with an AI-first approach, today announced the formation of its Scientific Advisory Board (SAB).”

2. E2 Isomorphic Labs announces new Scientific Advisory Board - Isomorphic Labs Isomorphic Labs · 9 January 2023 Own record

   “The scientific advisors are Nobel Prize laureates Jennifer Doudna, David MacMillan, Paul Nurse and Venki Ramakrishnan. As the inaugural members of the distinguished Isomorphic Labs Scientific Advisory Board”

3. E3 Isomorphic lands deals with Lilly, Novartis worth nearly $3B Fierce Biotech · 7 January 2024

   “The company’s scientific advisory board is stacked with four previous Nobel Prize winners, including CRISPR scientist Jennifer Doudna, Ph.D., Sir David MacMillan, Ph.D., Sir Paul Nurse, Ph.D., and Venki Ramakrishnan, Ph.D.”

Isomorphic Labs' official announcement of 9 January 2023 says it formed its Scientific Advisory Board that day (E1). The same announcement names Jennifer Doudna, David MacMillan, Paul Nurse and Venki Ramakrishnan as the board's inaugural members (E2). Independent coverage by Fierce Biotech in January 2024 confirms that all four laureates sit on the company's scientific advisory board (E3).